Skip to main content
. 2017 Nov 6;8:1336. doi: 10.1038/s41467-017-01399-2

Table 1.

Measurement of drug resistance of E. coli expressing A. baumannii MacA-MacB-TolC or transport inactive mutants

Component(s) expressed MIC (μg ml−1)
Macrolide (MacB substrates) AcrB substrates
EM CAM RXM AZM SPM LM ACR SDS
None (empty vector) 1.56 1.56 4.41 0.55 4.41 2.2 4.41 50.0
MacA-MacB(E172Q)-TolC 1.10 1.56 1.56 0.39 4.41 1.10 4.41 50.0
MacA-MacB-TolC 2.21 2.21 6.25 0.55 6.25 3.13 4.41 50.0
MacA-MacB 1.56 2.21 1.56 0.28 4.41 1.10 4.41 50.0
MacA-TolC 1.10 1.56 1.56 0.28 2.21 1.10 4.41 50.0
MacB-TolC 1.56 1.56 1.56 0.28 4.41 1.10 4.41 50.0
MacA-MacB(ΔC10)-TolC 0.78 1.10 1.56 0.28 2.21 1.10 4.41 50.0

EM, erythromycin; CAM, clarithromycin; RXM, roxithromycin; AZM, azithromycin; SPM, spiramycin; LM, leucomycin; ACR, acriflavine; SDS, sodium dodecyl sulfate

The resistance levels are shown as minimum inhibitory concentration (MIC) in µg ml−1determined by the agar dilution method. Values are based on data shown in Fig. 1. Cells expressing the inactive Walker B E172Q MacB mutant were used as a negative control rather than non-expressing cells that lack the expression of foreign protein. Drug resistance is restored by expression of the functional MacA-MacB-TolC tripartite complex. AcrB substrates acriflavine and SDS are not transported by MacA-MacB-TolC. The MacB mutant lacking the carboxy-terminal coupling helix, CH2 is abbreviated as MacB(ΔC10)